规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | 7,8-Dihydroxyflavone (7,8-DHF) is a potent and selective TrkB agonist that mimics the physiological actions of Brain-derived neurotrophic factor (BDNF). 7,8-DHF (500 nM) protected primary neurons from Aβ-induced toxicity and promoted dendrite branching and synaptogenesis. Chronic oral administration of 7,8-DHF activated TrkB signaling and prevented Aβ deposition in transgenic mice that coexpress five familial Alzheimer's disease mutations (5XFAD mice). Moreover, 7,8-DHF inhibited the loss of hippocampal synapses, restored synapse number and synaptic plasticity, and prevented memory deficits[3]. 7,8-DHF activated the Nrf2 signaling pathway in primary chondrocytes[4]. 7,8-DHF might be capable of alleviating the jejunal contractile damage caused by IR (ischaemia-reperfusion) through activation of TrkB and augmentation of M3 expression[5]. 7,8-DHF (5 mg/kg; i.p.) administration conferred beneficial effects against alcohol and HFD-induced memory deficit via its unique antioxidant, anti-inflammatory, anti-apoptotic potential, along with the activation of TrkB/BDNF signaling pathway in the hippocampus[6]. |
Concentration | Treated Time | Description | References | |
Primary hippocampal neurons | 250 nM | Activate TrkB receptor | Transl Neurodegener. 2016 Jan 6;5:2. | |
neonatal rat ventricular myocytes (NRVMs) | 100 nM | 10 min | 7,8-DHF increased ERK phosphorylation levels, similar to LM22A-4 | Circ Res. 2023 Mar 31;132(7):867-881. |
adult murine ventricular myocytes | 2.5 μM, 5 μM, 10 μM | 7,8-DHF dose-dependently increased sarcomere shortening and whole Ca2+ transient, similar to LM22A-4 | Circ Res. 2023 Mar 31;132(7):867-881. | |
primary cortical neurons | 500 nM | 3 days | 7,8-DHF significantly increased the total dendritic length and branching complexity of neurons. | Neuropsychopharmacology. 2014 Feb;39(3):638-50. |
locus coeruleus (LC) neurons | 500 nM | 18 h | 7,8-DHF significantly reduced Aβ-induced neuronal apoptosis, protecting neurons from Aβ toxicity. | Neuropsychopharmacology. 2014 Feb;39(3):638-50. |
rat primary cortical neurons | 500 nM | 18 h | 7,8-DHF significantly reduced Aβ-induced neuronal apoptosis, protecting neurons from Aβ toxicity. | Neuropsychopharmacology. 2014 Feb;39(3):638-50. |
Administration | Dosage | Frequency | Description | References | ||
Mice | Traumatic brain injury model | Intraperitoneal or oral administration | 5 mg/kg | Administration at 3 hours post-injury | Reduce brain tissue damage | Transl Neurodegener. 2016 Jan 6;5:2. |
Mice | 5XFAD transgenic mouse model of AD | Oral (via drinking water) | 5 mg/kg | Daily administration for 4 months | 7,8-DHF activated TrkB signaling pathways, reduced Aβ deposition, prevented hippocampal synaptic loss, restored synaptic plasticity, and improved spatial memory deficits. | Neuropsychopharmacology. 2014 Feb;39(3):638-50. |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
3.93mL 0.79mL 0.39mL |
19.67mL 3.93mL 1.97mL |
39.33mL 7.87mL 3.93mL |
CAS号 | 38183-03-8 |
分子式 | C15H10O4 |
分子量 | 254.24 |
SMILES Code | OC1=CC=C2C(=O)C=C(OC2=C1O)C1=CC=CC=C1 |
MDL No. | MFCD00006836 |
别名 | 二羟基黄酮水合物 ;7,8-DHF |
运输 | 蓝冰 |
InChI Key | COCYGNDCWFKTMF-UHFFFAOYSA-N |
Pubchem ID | 1880 |
存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere,2-8°C |
溶解方案 |
DMSO: 105 mg/mL(413 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|